Pain Cloud® Launch: A Collaboration between EptivA and Infopoly Ltd., creating an advanced solution to Pain Research

EptivA United Kingdom England United States of America

from high-quality molecular databases, providing unbiased analyses linking research targets to optimised disease phenotypes.

Our Personalized Analgesics® bioinformatic approach creates thousands of nodes of data via novel human-focused network biology, all linked to our proprietary Pain Landscape® database of thousands of diseases.

With Pain Cloud's technology, analgesic development will be quicker, less expensive, and more successful. It is hoped safer, efficient, and targeted pain medications, utilizing insights from Pain Cloud, will become available to those who need it most soon.

Mark J Field, CEO and Co-founder of EptivA Therapeutics, says: "Infopoly have further developed our novel methodology, enabling an Advanced Pain Management Solutions B2B platform. By utilising Pain Cloud, researchers can solve the cost-intensive traditional R&D with a streamlined process to precisely match targets and mechanisms to specific patient groups saving time and reducing expenditure." Visit https://paincloud.ai for more information.

Media contact:
Mark J. Field PhD MSc FRSB FIScT
Co-Founder & CEO, EptivA Therapeutics
[e-mail]
[phone]

View original content:https://www.prnewswire.co.uk/news-releases/pain-cloud-launch-a-collaboration-between-eptiva-and-infopoly-ltd-creating-an-advanced-solution-to-pain-research-302187154.html